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Abst rac t - -A  mathematical model for endothelial cell migration during tumour-induced angio- 
genesis is presented. A possible xplanation, in terms of desensitisation f cell-surface r ceptors, is
given for the experimentally observed fact that without cell proliferation tumour vaseularisation is 
never achieved. 
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1. INTRODUCTION 
Angiogenesis (the formation of blood vessels) is essential for successful growth and development 
of solid tumours. Without the capillary network to supply blood and remove waste products, 
the tumour remains in a dormant avascular state. To facilitate angiogenesis, the tumour secretes 
chemicals, collectively known as tumour angiogenesis factors, TAF [1], which induce neighbouring 
endothelial cells (EC) to degrade their basal lamina and begin to migrate into the extracellular 
matrix (ECM) toward the turnout [2]. The ECM is the barrier that the EC have to overcome in 
order to achieve vascularisation. Consisting of interstitial tissue, collagen fibre, fibronectin fibrils 
and fibronectin, as well as other components [3], the ECM is fibrous and as such can guide the 
growth of capillary sprouts. Fibronectin is known to enhance EC adhesion to collagen [4] and is 
also produced by EC themselves [5]. Therefore, as well as moving in response to the chemotactic 
effect of TAF, EC migration is also regulated by the haptotactic effect of fibronectin [4,6]. Sholley 
et al. [7] showed that the vascular sprouts cannot complete angiogenesis successfully unless the EC 
close to the sprout tips undergo mitosis. Provided mitosis occurs, the sprouts continue to grow 
and begin to branch and form loops (anastomoses) through which blood eventually circulates. 
As the sprouts approach the tumour, their branching dramatically increases, and the tumour is 
eventually penetrated, resulting in vascularisation [2]. If EC mitosis is prevented [7], outgrowth 
of the capillary sprouts is severely reduced, resulting in the formation of a restricted network 
which never reaches the tumour. 
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This paper dicusses a possible mechanism to explain why vascular sprouts stop migrating 
towards the tumour in the absence of mitosis. In particular, we consider a one-dimensional 
equation for EC migration involving diffusion, chemotaxis, and haptotaxis terms. Through both 
steady state and numerical analysis we show that this equation can produce vascular sprouts that 
fail to reach the tumour and therefore prevent vascularisation. 
2. MODEL 
There have been many mathematical models describing tumour angiogenesis, ncluding deter- 
ministic [8,9] and stochastic models [10]. All of these models have terms which represent random 
migration (diffusion), biased migration (chemotaxis), growth and death of EC. None of these 
models consider the effects of fibronectin or the ECM, although Chaplain [8] assumes that EC 
diffusion is density dependent, therefore modelling the inhibitory effect of the ECM. A recent 
model by Orme and Chaplain [11] does consider the effects of fibronectin, showing that hapto- 
taxis can produce EC aggregation from which the capillary sprouts eventually form. Because this 
model is for the early stages of tumour angiogenesis, it does not consider chemotaxis. 
Since initially there is no EC proliferation and given that EC have a long half-life [12] (allowing 
us to omit a death term), our equation describing EC migration is 
On 02n 0 ( ~x) 0 (~x)  -~ - -  D-ff-~x2 Ox X(c)n - P~x n , (1) 
where nix, t) is the EC density, D, X(c), and p are the diffusion, chemotactic, and haptotactic 
parameters, respectively, with c(x, t) and f(x, t) representing the TAF and fibronectin concentra- 
tions in the 1D domain x E [0, 1]. Following Chaplain [8], we assume that the two chemicals (TAF, 
fibronectin) are in some quasi-steady state, and as such, we have c(x, t) - c(x), f(x, t) - f(x). 
The chemotactic coefficient X(c) in nearly all tumour angiogenesis models is assumed to 
be constant, meaning that EC always respond to a chemo-sensory stimulus (e.g., TAF) in 
the same manner egardless of the stimulus concentration. Models of the cellular slime mold 
Dictyostelium discoideum [13,14] have chemotactic coefficients that depend on the concentration 
of the chemo-sensory stimulus, i.e., the lower the concentration, the higher the coefficient. This 
is due to the manner in which the cell receptors of D. discoideum can become desensitised to the 
stimulus (cAMP). We shall assume that EC receptors become desensitised in a similar manner 
to high concentrations of TAF and therefore choose 
X0 
X(c)= l +ac'x~'~ ) (2) 
where X0 and c~ are positive contants representing the maximum chemotactic response and the 
severity of desensitisation. 
We impose no-flux boundary conditions on (1), that is, 
On n (X(c) O~x Of) Ox D + P~x at x = 0, 1. (3) 
Assuming that the tumour is located at x = 1 and the parent vessel of the EC is at x = 0, we 
take 
n(x,O) = exp -x2/°'°m, 0 < x < 1, (4) 
as the initial distribution of capillary sprouts. Other qualitatively similar forms for nix , O) are 
possible, e.g., exp(-x/0.001) produces a slightly wider initial distribution of EC, but evolves to 
the same steady state. These simple forms are chosen to model the fact the EC in the initial 
capillary buds are located close to the parent vessel. As discussed in the Introduction, fibronectin 
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is produced by EC and also exists in the ECM; we therefore approximate the fibronectin concen- 
tration by a decaying exponential function, 
f (x )  = exp -x2/E, 0 < x < 1, (5) 
where e is a small positive constant. Since TAF is produced by the tumour, located at x = 1, we 
use a similar decaying form, 
c(x) = exp -(l-x)2/e, 0 < x < i, (6) 
with e as in (5). Plots of (4)-(6) are given in Figure i, for e = 0.45. Clearly, as e increases the 
intersection between f and c grows. These functions, f and c, are chosen to give the correct 
qualitative forms, assumed for the stationary concentrations of fibroneetin and TAF. Fibronectin 
is produced by the EC in the parent vessel (at x = 0) and decays across the ECM. In contrast, 
TAF is produced by the tumour cells (at x -- 1) and decays to a lower level at the opposite side 
(x = 0). Other qualitatively similar choices of f and c are possible, i.e., monotonic decreasing 
functions. 
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Figure 1. Initial endothelial cell concentrat ion (4) and profiles of possible f ibronectin 
(.f(x)) and TAF (c(x)) concentrat ions (5) and (6) with ~ = 0.45. 
3. STEADY STATE AND NUMERICAL  SOLUTIONS 
Setting on = 0 and integrating (1) with respect o x gives 
DOn Oc Of  
E1 = cOx - X(c)n'-~x - Pn ~x " 
Applying the boundary conditions (3) gives E1 = 0, and hence, 
__  Xo Oc + P~x " On = n 1 
cox D + ac COx 
Solving (7) using an integrating factor yields the steady state solution 
n(x)  = E3 exp L~aa 
(7) 
(8) 
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where E3 is a constant of integration chosen to ensure conservation of EC. This solution is 
dependent on the magnitude of the parameter ~, since for small ~ the effects of TAF dominate (8), 
and for large a the effects of fibronectin dominate. Clearly, (8) also depends on the forms of c 
and f .  However, a could always be chosen such that the EC are drawn towards the source of the 
fibronectin at x = 0. 
Chaplain [8] estimated the scaled diffusion coefficient D = DEC/DTA F = 0.001; we therefore 
take D = 0.001, since the unbiased migration of EC is certainly small compared to the biased 
migration. The chemotactic coefficient X0 was also estimated by Chaplain [8] between 0.3 and 1, 
and we set X0 = 0.38. The haptotaxis coefficient p has been estimated by Orme and Chaplain [11]. 
However, this was for a model that did not involve chemotaxis. Since EC generally reach the 
tumour if mitosis occurs, it is reasonable to assume that X0 > P; we therefore take p = 0.34. 
For angiogenesis to begin, we require the concentration of TAF, c(x) > 0, in the vicinity of the 
EC (x ~ 0). By increasing the parameter e of (5) and (6), we increase the amount of fibronectin 
and TAF throughout the whole region (0 < x < 1) as well as increasing the intersection between 
f and c. The fact that fibronectin and TAF are "pulling" the EC in opposite directions makes 
this intersection important. For without sufficient intersection between f and c, the EC would 
not move from their initial position. Paweletz and Knierim [12] observed experimentally that EC 
moved up and down the capillary sprouts, implying that such an intersection between TAF and 
fibronectin may exist. Along with the above parameters, it was found that a value of e -- 0.45 
(see Figure 1) produced results which agreed well with experimental observations, i.e., a small 
amount of capillary outgrowth which stopped completely after a few days. 
Figure 2 shows the steady state solution obtained from (8) for a range of values of a. As 
(the desensitisation coefficient) decreases, the chemotactic effect of the TAF desensitises at a 
higher concentration and subsequently causes the steady state to move further to the right. This 
implies that with this mechanism of desensitisation, the EC can only move part of the distance 
to the tumour. It seems reasonable that when proliferation occurs after this steady state is 
reached, then the newly formed cells with sensitised sites will allow further migration towards 
the turnout. Experimental observation of capillary network formation has shown that the EC 
do in fact migrate towards the tumour in repeated steps of sprout growth, cell proliferation, and 
loop formation [2]. Sholley et al. [7] showed that EC without proliferation only migrate 30% of 
the distance that proliferating EC cover. Therefore the steady state solution for ~ = 0.6 agrees 
with this, since the maximum position EC can move to is x = 1. 
To verify the steady state results, we solved equation (1) numerically using the NAG routine 
D03PCF. Taking ~ = 0.6, the same parameter values used for Figure 2 and the initial and 
boundary conditions given by (4) and (3), we produced Figure 3. This shows clearly the migration 
of the EC. The steady state is reached at t ~ 10 and matches the analytical solution closely. 
4. CONCLUSIONS AND 
DISCUSSION 
We have developed a possible mechanism to explain why capillary network formation is only 
partially successful in the absence of EC proliferation. This mechanism is dependent upon the idea 
that EC have a limited sensitivity to chemical gradients which saturates at high concentrations. 
The haptotactic effect of fibronectin also plays an important role by drawing the EC back towards 
their source. We note that this is observed experimentally, i.e., EC do move backwards along 
capillary sprouts [12]. Several experimenters have shown that EC migration is enhanced in a gra- 
dient of fibronectin alone [4,6] and that EC-fibronectin interactions are very important [15-17]. 
The model is therefore xperimentally verifiable, for, by placing sources of both TAF and fi- 
bronectin at opposite ends of an appropriate test chamber (e.g., a square petri dish with a 
suitable substratum), opposing chemical gradients would be produced. The EC would then be 
placed somewhere in the middle of the chamber and their movement monitored cf. [4,6,7,15-17]. 
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Endothelial cell steady state solutions (8) for a range of a with the pa~ 
rameter values: e = 0.45, D = 0.001, X0 = 0.38, p : 0.34. Decreasing a (i.e., less 
desensitisation) permits the network to move closer to the tumour. 
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Figure 3. Numerical solution of (1) with a = 0.6 and the same parameters a Figure 2, 
for t ranging from 0.5 to 500. The two steady states are almost identical. 
It may also be possible, for example, to use a Boyden chamber assay or a two-dimensional col- 
lagen gel in order to quantitat ively measure the key parameter in the model, the desensit isation 
6oefficient a.  This could be done in a manner  similar to [18], where the chemotactic function for 
neutrophi l  response to a peptide (FMLP) was estimated. 
Finally, we note that  while the idea that  EC have a saturat ing sensitivity to TAF  is possible, 
it might also be possible that  they have a similar sensitivity to fibronectin. If this were the case, 
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then it would be necessary for sensit isation-desensitisation to occur more than once, in order to 
prevent EC migrat ion to the TAF  source (without EC proliferation). 
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